African Pharmaceutical Regulatory Intelligence
PACLITAXEL
165 registrations across 14 African markets— 118 active
Markets with PACLITAXEL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| P-Tax 300mg/50ml Solution for injection | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jun 2031 |
| P-TAX 260mg/43.4ml Solution for injection | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jun 2031 |
| PACLICAN 300 SOLUTION; INFUSION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | Apr 2031 |
| PACLICAN 100 SOLUTION; INJECTION | 🇿🇼Zimbabwe | RHAEGAL PHARMACEUTICALS | active | Nov 2030 |
| PACLITAXEL INJECTION | 🇬🇭Ghana | — | active | Dec 2029 |
| PACLITAXEL INJECTION | 🇬🇭Ghana | — | active | Dec 2029 |
| BRAVIFO 300mg Injection | 🇿🇲Zambia | MSN Laboratories Private Limited | active | Dec 2029 |
| PACLITERO 300 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Sept 2029 |
| PAXOL INJECTABLE; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Sept 2029 |
| PACLITERO 30 Injection | 🇷🇼Rwanda | HETERO LABS LIMITED | active | Aug 2029 |
| Intaxel 100mg/16.7ml Injection Solution for Injection | 🇿🇲Zambia | FRESENIUS KABI SOUTH AFRICA (PTY) LIMITED | active | Jul 2029 |
| PACLITERO 100 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Mar 2029 |
| PACLITERO 30 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Mar 2029 |
| NANOGIX 300 | 🇿🇦South Africa | Ranbaxy Pharmaceuticals (Pty) Ltd | active | Feb 2029 |
| NANOGIX 100 | 🇿🇦South Africa | Ranbaxy Pharmaceuticals (Pty) Ltd | active | Feb 2029 |
| P-TAX 300 SOLUTION; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Dec 2028 |
| P-TAX 260 SOLUTION; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Dec 2028 |
| Paclitaxel Sandoz 6 mg/mL Concentrate for Solution for Infusion** Solution for infusion | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2028 |
| PACLITAXEL MYLAN SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Dec 2027 |
| PACLITAXEL MYLAN SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Dec 2027 |
| PACLITAXEL MYLAN SOLUTION; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Dec 2027 |
| PACLIALL POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | PANACEA BIOTEC PHARMA LIMITED | active | Dec 2027 |
| Paclitaxel 100mg Solution For Infusion | 🇰🇪Kenya | Paclitaxel 100mg | active | Sept 2027 |
| Paclitaxel 300mg Solution For Infusion | 🇰🇪Kenya | Paclitaxel 300mg | active | Sept 2027 |
| PACLITAXEL SANDOZ CONCENTRATE FOR SOLUTION FOR INFUSION (Each vial contains Paclitaxel 6mg/ml) | 🇬🇭Ghana | — | active | Dec 2026 |
| Paclitaxel 100 mg/16.7 mL Concentrate For Solution For Infusion** Concentrate for solution for infusion | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Dec 2026 |
| Paclitaxel 300 mg/50 mL Concentrate For Solution For Infusion** Concentrate for solution for infusion | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Dec 2026 |
| PACLITAXEL SANDOZ CONCENTRATE FOR SOLUTION FOR INFUSION | 🇬🇭Ghana | — | active | Dec 2026 |
| PACLITAXEL SANDOZ CONCENTRATE FOR SOLUTION FOR INFUSION (Each vial contains Paclitaxel 6mg/ml) | 🇬🇭Ghana | — | active | Dec 2026 |
| PACLITAXEL SANDOZ CONCENTRATE FOR SOLUTION FOR INFUSION | 🇬🇭Ghana | — | active | Dec 2026 |
| ASPEN PACLITAXEL 30 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| ASPEN PACLITAXEL 260 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| ASPEN PACLITAXEL 300 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| ASPEN PACLITAXEL 100 mg/16,67 ml | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Sept 2025 |
| PLIXEL 300 mg | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Aug 2025 |
| PLIXEL | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Aug 2025 |
| PLIXEL 100 mg | 🇿🇦South Africa | Safeline Pharmaceuticals (Pty) Ltd | suspended | Aug 2025 |
| SANDOZ PACLITAXEL 100 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| SANDOZ PACLITAXEL 30 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| SANDOZ PACLITAXEL 300 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| BIOLYSE PACLITAXEL FOR INJECTION | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | Jul 2025 |
| PACLICURE 300MG/50ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2024 |
| ANZATAX | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| EBETAXEL 30 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Mar 2022 |
| EBETAXEL 300 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Mar 2022 |
| EBETAXEL 150 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Mar 2022 |
| EBETAXEL 100 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Mar 2022 |
| PAXUS 100MG INJECTION 1X16.7ML VIAL | 🇳🇬Nigeria | BOUCIA LIMITED NO. 1 | expired | Jun 2021 |
| PAXUS 30MG INJECTION 1X5ML VIAL | 🇳🇬Nigeria | BOUCIA LIMITED NO. 1 | expired | Jun 2021 |
| PACLITAXEL NEAPOLIS Solution injectable pour perfusion / 6 mg/ml (100mg) | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
Showing 50 of 165 registrations. Sign up free to search and export all.
PACLITAXEL in Africa — Regulatory Overview
PACLITAXEL is registered across 14 African markets with 165 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Senegal and 10 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 165 registrations, 118 (72%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.